Clinical Trial: To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.
Brief Summary: To evaluate the long-term safety of pregabalin in refractory partial epilepsy.
Detailed Summary:
Sponsor: Pfizer
Current Primary Outcome: Safety
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Pfizer
Dates:
Date Received: August 30, 2005
Date Started: November 1997
Date Completion: October 2005
Last Updated: December 28, 2006
Last Verified: December 2006